PostEra

Company profile

About PostEra

PostEra is building a modern 21st century biopharma that uses artificial intelligence to transform drug discovery. The company has developed Proton, an end-to-end machine learning platform that closes the Design-Make-Test cycle of medicinal chemistry. PostEra focuses on the chemistry stage of drug discovery, addressing the iterative three-step cycle of designing molecules, synthesizing them, and testing their properties. Their platform combines proprietary data with chemistry foundation models to design molecules that satisfy the competing properties required for drug candidates, while state-of-the-art synthesis planning ensures every designed molecule has a reliable synthetic route. PostEra advances small molecule programs through partnerships with leading biopharma companies while also developing its own internal pipeline. The company has established over $1 billion in AI partnerships with major pharmaceutical companies including Pfizer and Amgen, as well as the NIH. PostEra also launched and led COVID Moonshot, the world's largest open-science drug discovery effort. The company's mission is to accelerate medicinal chemistry and bring more cures to patients by making drug discovery faster, more optimized, and more successful.

Company description · PostEra official website